In Vivo Sustained Release of Peptide Vaccine Mediated by Dendritic Mesoporous Silica Nanocarriers

In Vivo Sustained Release of Peptide Vaccine Mediated by Dendritic Mesoporous Silica Nanocarriers

Mesoporous silica nanoparticles have drawn increasing attention as promising candidates in vaccine delivery. Previous studies evaluating silica-based vaccine delivery systems concentrated largely on macromolecular antigens, such as inactivated whole viruses. In this study, we synthesized dendritic m...

Full description

Bibliographic Details
Main Authors: Weiteng An, Sira Defaus, David Andreu, Pilar Rivera-Gil
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
dendritic mesoporous silica nanoparticles
peptide vaccines
sustained and controlled release
foot-and-mouth disease virus
nanovaccine
immunogenicity
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.684612/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.684612/full

Similar Items